The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Nov. 05, 2002

Filed:

Feb. 02, 2000
Applicant:
Inventors:

Timothy J. Ohara, San Ramon, CA (US);

Mahyar Z. Kermani, Pleasanton, CA (US);

Assignee:

LifeScan, Inc., Milpitas, CA (US);

Attorney:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
G01N 2/726 ; G01N 3/386 ; G01N 3/300 ;
U.S. Cl.
CPC ...
G01N 2/726 ; G01N 3/386 ; G01N 3/300 ;
Abstract

Methods and devices for determining the concentration of an analyte in a physiological sample are provided. In the subject methods, the physiological sample is introduced into an electrochemical cell having a working and reference electrode. A first electric potential is applied to the cell and the resultant cell current over a period of time is measured to determine a first time-current transient. A second electric potential of opposite polarity is then applied and a second a time-current transient is determined. The preliminary concentration of the analyte is then calculated from the first and/or second time-current transient. This preliminary analyte concentration less a background value is then multiplied by a hematocrit correction factor to obtain the analyte concentration in the sample, where the hematocrit correction factor is a function of the preliminary analyte concentration and the variable &ggr; of the electrochemical cell. The subject methods and devices are suited for use in the determination of a wide variety of analytes in a wide variety of samples, and are particularly suited for the determination of analytes in whole blood or derivatives thereof, where an analyte of particular interest is glucose.

Published as:
CA2398203A1; WO0157510A2; AU3297401A; WO0157510A3; US2002125145A1; KR20020077409A; EP1252514A2; US6475372B1; CN1394280A; TW520439B; AR027345A1; CZ20021298A3; HK1049881A1; JP2003521708A; MXPA02005797A; RU2002116217A; PL358492A1; CN1193228C; US6890421B2; IL149662A; US2005176153A1; AU783311B2; RU2262890C2; EP1252514B1; ATE313794T1; DE60116056D1; EP1645876A2; DK1252514T3; ES2254368T3; DE60116056T2; HK1049881B; MY127335A; RU2005123794A; EP1645876A3;

Find Patent Forward Citations

Loading…